These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


526 related items for PubMed ID: 23042213

  • 1. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R, Marutle A, Nordberg A.
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [Abstract] [Full Text] [Related]

  • 2. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A.
    J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
    [Abstract] [Full Text] [Related]

  • 3. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M, Hellström-Lindahl E.
    Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
    [Abstract] [Full Text] [Related]

  • 4. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain.
    Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I, Voytenko L, Nordberg A.
    J Neuroinflammation; 2013 Jul 23; 10():90. PubMed ID: 23880036
    [Abstract] [Full Text] [Related]

  • 5. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
    Rousseau SJ, Jones IW, Pullar IA, Wonnacott S.
    Neuropharmacology; 2005 Jul 23; 49(1):59-72. PubMed ID: 15992581
    [Abstract] [Full Text] [Related]

  • 6. Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons.
    Fu W, Jhamandas JH.
    J Neurophysiol; 2003 Nov 23; 90(5):3130-6. PubMed ID: 12890800
    [Abstract] [Full Text] [Related]

  • 7. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
    Roberts JP, Stokoe SA, Sathler MF, Nichols RA, Kim S.
    J Biol Chem; 2021 Nov 23; 296():100402. PubMed ID: 33571523
    [Abstract] [Full Text] [Related]

  • 8. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
    Parri HR, Hernandez CM, Dineley KT.
    Biochem Pharmacol; 2011 Oct 15; 82(8):931-42. PubMed ID: 21763291
    [Abstract] [Full Text] [Related]

  • 9. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q, Xie X, Emadi S, Sierks MR, Wu J.
    Neuropharmacology; 2015 Oct 15; 97():457-63. PubMed ID: 25959067
    [Abstract] [Full Text] [Related]

  • 10. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J, Wu J.
    Int Rev Neurobiol; 2015 Oct 15; 124():275-92. PubMed ID: 26472533
    [Abstract] [Full Text] [Related]

  • 11. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF, Guan ZZ, Bogdanovic N, Nordberg A.
    Exp Neurol; 2005 Mar 15; 192(1):215-25. PubMed ID: 15698636
    [Abstract] [Full Text] [Related]

  • 12. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
    Feuerbach D, Nozulak J, Lingenhoehl K, McAllister K, Hoyer D.
    Neurosci Lett; 2007 Apr 06; 416(1):61-5. PubMed ID: 17314009
    [Abstract] [Full Text] [Related]

  • 13. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
    Qi XL, Nordberg A, Xiu J, Guan ZZ.
    Neurochem Int; 2007 Apr 06; 51(6-7):377-83. PubMed ID: 17493709
    [Abstract] [Full Text] [Related]

  • 14. beta-Amyloid activates presynaptic alpha7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts.
    Khan GM, Tong M, Jhun M, Arora K, Nichols RA.
    Eur J Neurosci; 2010 Mar 06; 31(5):788-96. PubMed ID: 20374280
    [Abstract] [Full Text] [Related]

  • 15. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
    Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, Zhang J, Lucero L, Wang M, Sierks M, Hu G, Chang Y, Lukas RJ, Wu J.
    J Neurosci; 2009 Jan 28; 29(4):918-29. PubMed ID: 19176801
    [Abstract] [Full Text] [Related]

  • 16. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS, Moreth J, Kussmaul L, Rast G, Rosenbrock H.
    Brain Res Bull; 2013 Jul 28; 96():28-38. PubMed ID: 23639920
    [Abstract] [Full Text] [Related]

  • 17. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.
    Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A.
    Brain; 2013 Jul 28; 136(Pt 7):2217-27. PubMed ID: 23757761
    [Abstract] [Full Text] [Related]

  • 18. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
    Aracava Y, Pereira EF, Maelicke A, Albuquerque EX.
    J Pharmacol Exp Ther; 2005 Mar 28; 312(3):1195-205. PubMed ID: 15522999
    [Abstract] [Full Text] [Related]

  • 19. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
    Ikonomovic MD, Wecker L, Abrahamson EE, Wuu J, Counts SE, Ginsberg SD, Mufson EJ, Dekosky ST.
    Arch Neurol; 2009 May 28; 66(5):646-51. PubMed ID: 19433665
    [Abstract] [Full Text] [Related]

  • 20. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A.
    Neurodegener Dis; 2010 May 28; 7(6):379-88. PubMed ID: 20689242
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.